Prof. Dr. SAFİYE ATLAS TÜLİN ERGUN

Yayın Ağı

Makaleler 106

1. Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy.

Apti Sengun O., Ergun T., Guctekin T., Alibaz Oner F.

Microvascular research , cilt.150, ss.104591, 2023 (SCI-Expanded)

2. COMMON FEMORAL VEIN THICKNESS MEASUREMENT AS A DIAGNOSTIC TEST IN INCOMPLETE BEHCET'S DISEASE

Alibaz-Oner F., Ergelen R., Temiz F., Agackiran S. K., Soydemir E., Ergun T., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1446-1447, 2022 (SCI-Expanded)

3. PROGNOSTIC VALUE OF COMMON FEMORAL VEIN WALL THICKNESS IN BEHCET DISEASE: A PROSPECTIVE FOLLOW-UP STUDY

Abacar K., Ergelen R., Temiz F., Yildiz Y., Ergun T., DİRESKENELİ R. H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1041, 2022 (SCI-Expanded)

4. EARLIER AND MORE AGGRESSIVE TREATMENT OF MAJOR ORGAN INVOLVEMENT WITH BIOLOGICS MAY PREVENT RELAPSES OR FURTHER NEW ORGAN INVOLVEMENT IN A SUBGROUP OF BEHCET'S DISEASE PATIENTS

Bozkurt T., Karabacak M., Karatas H., Agackiran S. K., Ergun T., DİRESKENELİ R. H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.345-346, 2022 (SCI-Expanded)

5. The assessment of presenteeism and activity impairment in Behçet's syndrome and recurrent aphthous stomatitis: a multicentre study.

Karacayli U., Adesanya A., Aksoy A., Belem J. M. F. M., Cardin N. B., Sarı F. B., et al.

Rheumatology (Oxford, England) , cilt.61, sa.4, ss.1538-1547, 2022 (SCI-Expanded, Scopus)

6. Use of Therapist Rotation Model for Eye Movement Desensitization and Reprocessing (EMDR) in a Patient with Atopic Dermatitis

Yasar A. B., YANARTAŞ Ö., Cam C. S., BUDAK C., Topcuoglu V., ERGUN S. A. T.

PSYCHIATRY AND BEHAVIORAL SCIENCES , cilt.12, sa.1, ss.45-47, 2022 (ESCI)

7. Drug eruption: A mimicker of Coronavirus disease-2019 rash

ERGUN S. A. T., Ergenc I., SEVEN S., SEÇKİN GENÇOSMANOĞLU D., CÖMERT ÖZER E., AKTAŞ M., et al.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY , cilt.56, sa.1, ss.34-38, 2022 (ESCI) Sürdürülebilir Kalkınma

8. Editorial: Behcet's Disease: Epidemiology, Etiopathogenesis, Diagnosis and Treatment

Alpsoy E., Leccese P., Ergun S. A. T.

FRONTIERS IN MEDICINE , cilt.8, 2021 (SCI-Expanded)

9. Serum high-sensitivity C-reactive protein, tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Ozturk G. S., Ergun T., Eyuboglu İ., Akkiprik M.

CYTOKINE , cilt.144, 2021 (SCI-Expanded, Scopus)

10. Mesenchymal stem cells derived from human dental follicle modulate the aberrant immune response in atopic dermatitis

Zibandeh N., Genc D., Özgen Z., Duran Y., Goker K., Barış S., et al.

IMMUNOTHERAPY , cilt.13, ss.825-840, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

11. Pathergy Phenomenon.

Ergun T.

Frontiers in medicine , cilt.8, ss.639404, 2021 (SCI-Expanded)

12. The impact of antipsoriatic treatment on serum pro-BDNF, BDNF levels, depression, anxiety scores, and quality of life

Aksoy H., Ergun T., Akkiprik M., Peker Eyuboglu İ., Seckin Gencosmanoglu D., Cöbek Ünalan G. P., et al.

DERMATOLOGIC THERAPY , cilt.34, sa.2, 2021 (SCI-Expanded, Scopus)

13. Biyolojik Ajanlar Kanser Yapıyor mu?

Ergun S. A. T.

Türkiye Klinikleri Dermatoloji Dergisi , sa.1, ss.163-166, 2021 (Scopus)

14. Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease.

Alibaz-Oner F., Ergelen R., Yıldız Y., Aldag M., Yazici A., Cefle A., et al.

Rheumatology (Oxford, England) , cilt.60, sa.1, ss.288-296, 2021 (SCI-Expanded, Scopus)

15. Moderation analysis exploring associations between age and mucocutaneous activity in Behçet's syndrome: A multicenter study from Turkey.

MUMCU G., Yay M., Karacayli U., Aksoy A., Tas M. N., Armagan B., et al.

The Journal of dermatology , cilt.47, sa.12, ss.1403-1410, 2020 (SCI-Expanded, Scopus)

16. Decreasing incidence and severity of Behçet’s disease: a changing trend in epidemiological spectrum possibly associated with oral health

Mumcu G., Alibaz Ö., Ergun S. A. T., Direskeneli R. H.

Turkish journal of medical sciences , cilt.50, sa.SI-2, ss.1587-1590, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Netherton syndrome: Temporary response to dupilumab.

Aktas M., SALMAN A., Apti Sengun O., Comert Ozer E., Hosgoren Tekin S., Akin Cakici O., et al.

Pediatric dermatology , cilt.37, ss.1210-1211, 2020 (SCI-Expanded)

18. Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.

SALMAN A., Ergun T., Maria Gimenez-Arnau A.

The Journal of dermatological treatment , cilt.31, sa.2, ss.204-209, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature.

Aksoy A., Yazici A., Omma A., Cefle A., Onen F., Tasdemir U., et al.

International journal of rheumatic diseases , cilt.23, sa.2, ss.256-261, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Predictive factors for work-day loss in Behçet's syndrome: A multi-center study.

MUMCU G., Yay M., AKSOY A., Tas M. N., ARMAĞAN B., Sari A., et al.

International journal of rheumatic diseases , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Significant Effects of Body Image on Sexual Functions and Satisfaction in Psoriasis Patients.

Gunduz A., Topcuoglu V., Gunduz E. B. U., Ergun T., Gencosmanoglu D. S., Sungur M. Z.

Journal of sex & marital therapy , cilt.46, sa.2, ss.160-169, 2020 (SCI-Expanded)

22. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study.

Mumcu G., Karacayli Ü., Yay M., Aksoy A., Taş M., Armağan B., et al.

Clinical and experimental rheumatology , sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus)

23. Does illness perception associate with disease symptoms in Behçet's disease?

MUMCU G., YAĞAR F., Alibaz-Oner F., İNANÇ G. N., DİRESKENELİ R. H., ERGÜN T.

Internal and emergency medicine , cilt.14, sa.5, ss.691-697, 2019 (SCI-Expanded, Scopus)

24. Advanced Glycation End Products, a Potential Link between Psoriasis and Cardiovascular Disease: A Case-control Study.

Ergun T., Yazici V., YAVUZ D., Seckin-Gencosmanoglu D., Ozen G., SALMAN A., et al.

Indian journal of dermatology , cilt.64, sa.3, ss.201-206, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Oral health is a mediator for disease severity in patients with Behçet's disease: A multiple mediation analysis study.

Yay M., Celik Z., AKSOY A., Alibaz-Oner F., Inanc N., Ergun T., et al.

Journal of oral rehabilitation , cilt.46, sa.4, ss.349-354, 2019 (SCI-Expanded)

26. Expanding the differential diagnosis of raccoon eyes: sweet syndrome.

Salman A., Demir G., Cinel L., Oguzsoy T., Yildizhan G., Ergun T.

Journal of the European Academy of Dermatology and Venereology : JEADV , cilt.33, sa.1, 2019 (SCI-Expanded)

27. Assessment of cardiac and vessel functions in childhood psoriasis

ŞAYLAN ÇEVİK B., AKALIN F., Erolu E., Gencosmanoolu S., Ergun T.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.2, ss.617-623, 2019 (SCI-Expanded)

28. The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors.

Iris M., Ozcikmak E., AKSOY A., Alibaz-Oner F., Inanc N., Ergun T., et al.

European journal of rheumatology , cilt.5, sa.4, ss.240-243, 2018 (Hakemli Dergi)

29. Nodular mucinosis of the breast: A rare entity

SALMAN A., Cinel L., TÜRKÖZ H. K., Akbas G., Ergun T.

MARMARA MEDICAL JOURNAL , cilt.31, sa.2, ss.85-87, 2018 (ESCI) Sürdürülebilir Kalkınma

30. Hidradenitis suppurativa and the metabolic syndrome

Ergun T.

CLINICS IN DERMATOLOGY , cilt.36, sa.1, ss.41-47, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Prevalence of obesity in paediatric psoriasis and its impact on disease severity and progression.

Ergun T., SEÇKİN GENÇOSMANOĞLU D., Karakoc-Aydiner E., SALMAN A., Tekin B., BÜLBÜL BAŞKAN E., et al.

The Australasian journal of dermatology , cilt.58, sa.4, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream.

SALMAN A., SARAÇ G., Kuru B. C., Cinel L., YÜCELTEN A. D., Ergun T.

Pediatric dermatology , cilt.34, sa.6, 2017 (SCI-Expanded)

33. Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report.

Tekin B., SALMAN A., Ergun T.

Indian journal of dermatology, venereology and leprology , cilt.83, sa.5, ss.615-617, 2017 (SCI-Expanded)

34. Psoriasis and the liver: problems, causes and course.

Tula E., Ergun T., SEÇKİN GENÇOSMANOĞLU D., ÖZGEN Z., Avsar E.

The Australasian journal of dermatology , cilt.58, sa.3, ss.194-199, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

35. Internalized stigma in psoriasis: A multicenter study.

ALPSOY E., Polat M., FETTAHLIOĞLU KARAMAN B., KARADAĞ A. S., Kartal-Durmazlar P., Yalcin B., et al.

The Journal of dermatology , cilt.44, sa.8, ss.885-891, 2017 (SCI-Expanded)

36. Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature.

Salman A., Sarac G., Ergun T.

Dermatology online journal , cilt.23, sa.7, 2017 (Scopus)

37. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.

Deniz R., Tulunay-Virlan A., Ozdemir F. T., Unal A. U., Ozen G., Alibaz-Oner F., et al.

Immunological investigations , cilt.46, sa.5, ss.518-525, 2017 (SCI-Expanded)

38. Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

MUMCU G., Alibaz-Oner F., Oner S. Y., Ozen G., Atagunduz P., Inanc N., et al.

European journal of rheumatology , cilt.4, sa.2, ss.109-112, 2017 (TRDizin)

39. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.

Ergun T., SEÇKİN GENÇOSMANOĞLU D., ALPSOY E., BÜLBÜL BAŞKAN E., Saricam M. H., SALMAN A., et al.

The Journal of dermatology , cilt.44, sa.6, ss.630-634, 2017 (SCI-Expanded)

40. Horizontal melanonychia.

Salman A., Eser A., Atagunduz I. K., Ergun T.

Actas dermo-sifiliograficas , cilt.108, sa.5, ss.469-470, 2017 (Scopus)

41. Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis.

SALMAN A., Sonmez Y., Sahin H., Unal A. U., Direskeneli H., Cinel L., et al.

Dermatologic therapy , cilt.30, sa.3, 2017 (SCI-Expanded)

42. Bullous Sweet's Syndrome: Report of an Atypical Case Presenting with Ring-Like, Figurate Lesions.

SALMAN A., Berenjian A., Eser A., Kaymakci F. D., Cinel L., ATAGÜNDÜZ I., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.34, sa.1, ss.118-119, 2017 (SCI-Expanded)

43. Autoimmun-Progesteron-Dermatitis, die ein fixes Arzneimittelexanthem vortäuscht.

Salman A., Ergun T.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.15, sa.2, ss.217-219, 2017 (SCI-Expanded)

44. Autoimmune progesterone dermatitis mimicking fixed drug eruption.

SALMAN A., Ergun T.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.15, sa.2, ss.219-220, 2017 (SCI-Expanded)

45. Tumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis: A report of four cases with a literature review.

Ergun T., SEÇKİN GENÇOSMANOĞLU D., SALMAN A., Qzgen Z., Ocak E. S., Avsar E., et al.

Indian journal of dermatology, venereology and leprology , cilt.83, sa.1, ss.55-59, 2017 (SCI-Expanded)

46. Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Ozdemir F. T., Demiralp E. E., Aydin S. Z., Atagunduz P., Ergun T., Direskeneli H.

European journal of rheumatology , cilt.3, sa.4, ss.146-152, 2016 (Hakemli Dergi)

47. Panniculitis in juvenile dermatomyositis: Report of a case and review of the published work.

SALMAN A., Kasapcopur O., Ergun T., Durmus Ucar A. N., Demirkesen C.

The Journal of dermatology , cilt.43, sa.8, ss.951-3, 2016 (SCI-Expanded)

48. Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease.

Alibaz-Oner F., ALDAĞ B., Aldag M., Unal A. U., MÜTİŞ ALAN A., TOPTAŞ T., et al.

Journal of vascular surgery. Venous and lymphatic disorders , cilt.4, sa.3, ss.301-6, 2016 (SCI-Expanded, Scopus)

49. Another adverse effect of vemurafenib: Gingival hyperplasia.

SALMAN A., Tekin B., Koca S., Akgul Babacan N., YUMUK P. F., Ergun T.

The Journal of dermatology , cilt.43, sa.6, ss.706-7, 2016 (SCI-Expanded)

50. Interstitial Mycosis Fungoides With Lichen Sclerosus-Like Clinical and Histopathological Features.

Tekin B., Kempf W., SEÇKİN GENÇOSMANOĞLU D., Ergun T., Yucelten D., Demirkesen C.

The American Journal of dermatopathology , cilt.38, sa.2, ss.138-43, 2016 (SCI-Expanded)

51. Atypical presentations of eosinophilic fasciitis.

Ergun T., SEÇKİN GENÇOSMANOĞLU D., SALMAN A., Ocak E. S., YÜCELTEN A. D., Direskeneli H., et al.

Indian journal of dermatology, venereology and leprology , cilt.82, sa.1, ss.47-52, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Assessment of left atrial volume and function in patients with psoriasis by using real time three-dimensional echocardiography.

Atas H., KEPEZ A., Bozbay M., SEÇKİN GENÇOSMANOĞLU D., Cincin A., SÜNBÜL M., et al.

Wiener klinische Wochenschrift , cilt.127, sa.21-22, ss.858-863, 2015 (SCI-Expanded)

53. Gómez-López-Hernández Syndrome: A Rare Cause of Bilateral Nonscarring Alopecia.

Saricam M. H., Tekin B., ÜNVER O., EKİNCİ G., Ergun T.

Pediatric dermatology , cilt.32, sa.6, 2015 (SCI-Expanded)

54. H syndrome: a multifaceted histiocytic disorder with hyperpigmentation and hypertrichosis.

Tekin B., Atay Z., Ergun T., Can M., TÜNEY D., Babay S., et al.

Acta dermato-venereologica , cilt.95, sa.8, ss.1021-3, 2015 (SCI-Expanded)

55. Management of Psoriasis

Ergun T.

TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY , cilt.9, sa.3, ss.132-137, 2015 (ESCI)

56. Unilateral cutaneous vasculitis: An uncommon presentation and a possible explanation

Tekin B., SALMAN A., Tuglular S., Guler D., Ozen G., Direskeneil H., et al.

Indian Journal of Dermatology, Venereology and Leprology , cilt.81, sa.5, ss.518-519, 2015 (SCI-Expanded)

57. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Van De Kerkhof P. C. M., Strohal R., Kubanov A., Valenzuela F., Lee J., Yakusevich V., et al.

LANCET , cilt.386, sa.9993, ss.552-561, 2015 (SCI-Expanded)

58. Cutaneous leishmaniasis mimicking verrucous carcinoma: A case with an unusual clinical course.

Selman A., YÜCELTEN A. D., SEÇKİN GENÇOSMANOĞLU D., Ergun T., Demircay Z.

Indian journal of dermatology, venereology and leprology , cilt.81, sa.4, ss.392-4, 2015 (SCI-Expanded)

59. Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions.

SÜNBÜL M., SEÇKİN GENÇOSMANOĞLU D., Durmus E., ÖZGEN Z., Bozbay M., Bozbay A., et al.

Heart and vessels , cilt.30, sa.3, ss.347-54, 2015 (SCI-Expanded)

60. Pseudoporphyria in a peritoneal dialysis patient.

VELİOĞLU A., Ergun T., Ozener C.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis , cilt.35, sa.2, ss.234-5, 2015 (SCI-Expanded)

61. The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents.

Ergun T., SEÇKİN GENÇOSMANOĞLU D., BÜLBÜL BAŞKAN E., Onsun N., ÖZGEN Z., Unalan P., et al.

International journal of dermatology , cilt.54, sa.5, ss.594-9, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

62. Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers.

Alibaz-Oner F., MUMCU G., Kubilay Z., Ozen G., Celik G., Karadeniz A., et al.

Clinical rheumatology , cilt.33, sa.12, ss.1773-6, 2014 (SCI-Expanded)

63. A new Mucocutaneous Activity Index for Behçet's disease.

MUMCU G., Inanc N., Taze A., Ergun T., DİRESKENELİ R. H.

Clinical and experimental rheumatology , cilt.32, sa.4 Suppl 84, 2014 (SCI-Expanded)

64. Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis.

Alibaz-Oner F., Karatay E., Akpinar I. N., Ergun T., Direskeneli H.

Clinical rheumatology , cilt.33, sa.2, ss.277-80, 2014 (SCI-Expanded)

65. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.

MUMCU G., Inanc N., Ozdemir F. T., Tulunay A., Eksioglu-Demiralp E., Ergun T., et al.

International journal of dermatology , cilt.52, sa.12, ss.1561-6, 2013 (SCI-Expanded, Scopus)

66. Salivary levels of HNP 1-3 are related to oral ulcer activity in Behçet's disease.

MUMCU G., Cimilli H., Karacayli U., Inanc N., Ture-Ozdemir F., Eksioglu-Demiralp E., et al.

International journal of dermatology , cilt.52, sa.10, ss.1198-201, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

67. Widespread psoriasis induced by rituximab in a patient with rheumatoid arthritis: an unexpected adverse reaction.

Ozen G., Ergun T., Oner S. Y., Demirkesen C., Inanc N.

Joint bone spine , cilt.80, sa.5, ss.545-7, 2013 (SCI-Expanded)

68. TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism is not increased in Behçet's disease patients in two ethnic cohorts.

Turunc G., Coskun D., Alibaz-Oner F., Coit P., Duzgun N., Alpsoy E., et al.

Clinical and experimental rheumatology , cilt.31, sa.3 Suppl 77, ss.54-6, 2013 (SCI-Expanded)

69. Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Behcet's disease.

MUMCU G., Cimilli H., Karacayli U., Inanc N., Ture-Ozdemir F., Eksioglu-Demiralp E., et al.

Archives of oral biology , cilt.57, sa.6, ss.642-6, 2012 (SCI-Expanded, Scopus)

70. Isotretinoin has no negative effect on attention, executive function and mood.

Ergun T., Seckin D., Ozaydin N., Bakar O., Comert A., Atsu N., et al.

Journal of the European Academy of Dermatology and Venereology : JEADV , cilt.26, sa.4, ss.431-9, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

71. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.

MUMCU G., Sur H., Inanc N., Karacayli U., Cimilli H., ŞİŞMAN KİTAPÇI N., et al.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology , cilt.38, sa.10, ss.785-91, 2009 (SCI-Expanded, Scopus)

72. Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease.

Mumcu G., Niazi S., Stewart J., Hagi-Pavli E., Gokani B., Seoudi N., et al.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology , cilt.38, sa.5, ss.406-9, 2009 (SCI-Expanded, Scopus)

73. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report.

Seckin D., Cerman A. A., Yildiz A., Ergun T.

Journal of drugs in dermatology : JDD , cilt.8, sa.5, ss.451-4, 2009 (SCI-Expanded)

74. Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behçet's disease.

Mumcu G., Inanc N., Aydin S. Z., Ergun T., Direskeneli H.

Clinical and experimental rheumatology , cilt.27, sa.2 Suppl 53, 2009 (SCI-Expanded, Scopus)

75. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients.

Ergun T., Inanc N., Tuney D., Kotiloglu E. K., Seckin D., Tetik C., et al.

International journal of dermatology , cilt.47, sa.9, ss.894-902, 2008 (SCI-Expanded)

76. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

Cerman A. A., Bozkurt S., Sav A., Tulunay A., Elbasi M. O., Ergun T.

The British journal of dermatology , cilt.159, sa.4, ss.820-6, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

77. Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behçet's disease.

Birtas-Atesoglu E., Inanc N., Yavuz S., Ergun T., Direskeneli H.

Clinical and experimental rheumatology , cilt.26, sa.4 Suppl 50, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.

Direskeneli H., Ergun T., Yavuz S., Hamuryudan V., Eksioglu-Demiralp E.

Clinical rheumatology , cilt.27, sa.3, ss.373-5, 2008 (SCI-Expanded, Scopus)

79. Successful use of etanercept in type I pityriasis rubra pilaris.

Seckin D., Tula E., Ergun T.

The British journal of dermatology , cilt.158, sa.3, ss.642-4, 2008 (SCI-Expanded)

80. The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis.

Mumcu G., Hayran O., Ozalp D. O., Inanc N., Yavuz S., Ergun T., et al.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology , cilt.36, sa.3, ss.147-52, 2007 (SCI-Expanded, Scopus)

81. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study.

Coemert A., Bekiroglu N., Guerbuez O., Ergun T.

American journal of clinical dermatology , cilt.8, sa.4, ss.235-8, 2007 (SCI-Expanded)

82. Prolidase deficiency associated with hemoglobin O trait and microcytic anemia

Aytug A., Ergun T., Ratip S., Elcioglu N., Gultepe M., Mercan E., et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.45, sa.7, ss.867-868, 2006 (SCI-Expanded)

83. Oral health related quality of life is affected by disease activity in Behçet's disease.

Mumcu G., Inanc N., Ergun T., Ikiz K., Gunes M., Islek U., et al.

Oral diseases , cilt.12, sa.2, ss.145-51, 2006 (SCI-Expanded, Scopus)

84. Intralesional tuberculin for treatment of refractory warts.

Kus S., Ergun T., Gun D., Akin O.

Journal of the European Academy of Dermatology and Venereology : JEADV , cilt.19, sa.4, ss.515-6, 2005 (SCI-Expanded)

85. TCR gamma delta (+) T-cell response to streptococcal antigens in patients with psoriasis.

Ergun T., Eksioglu-Demiralp E., Direskeneli H., Mumcu G., Gurbuz O.

Archives of dermatological research , cilt.296, sa.11, ss.536-8, 2005 (SCI-Expanded)

86. Clinical and immunological effects of azithromycin in Behçet's disease.

Mumcu G., Ergun T., Elbir Y., Eksioglu-Demiralp E., Yavuz S., Atalay T., et al.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology , cilt.34, sa.1, ss.13-6, 2005 (SCI-Expanded, Scopus)

87. Oral health is impaired in Behçet's disease and is associated with disease severity.

Mumcu G., Ergun T., Inanc N., Fresko I., Atalay T., Hayran O., et al.

Rheumatology (Oxford, England) , cilt.43, sa.8, ss.1028-33, 2004 (SCI-Expanded, Scopus)

88. Epidermolysis bullosa acquisita associated with vitiligo, Graves' disease and nephrotic syndrome.

Bakar O., Demircay Z., Ergun T.

International journal of dermatology , cilt.43, sa.5, ss.378-80, 2004 (SCI-Expanded)

89. MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement.

Atagunduz P., Ergun T., DİRESKENELİ R. H.

Clinical and experimental rheumatology , cilt.21, sa.4 Suppl 30, 2003 (SCI-Expanded, Scopus)

90. Low serum mannose-binding lectin levels in Behçet's disease.

Inanc N., Birtas E., Yavuz S., Ergun T., Direskeneli H.

Advances in experimental medicine and biology , cilt.528, ss.287-9, 2003 (SCI-Expanded)

91. HSP 60 expression in mucocutaneous lesions of Behçet's disease.

Ergun T., Ince U., Eksioglu-Demiralp E., Direskeneli H., Gurbuz O., Gurses L., et al.

Journal of the American Academy of Dermatology , cilt.45, sa.6, ss.904-9, 2001 (SCI-Expanded, Scopus)

92. Neutrophil activation in Behçet's disease.

Eksioglu-Demiralp E., DİRESKENELİ R. H., Kibaroglu A., Yavuz S., Ergun T., Akoglu T.

Clinical and experimental rheumatology , cilt.19, sa.5 Suppl 24, 2001 (SCI-Expanded, Scopus)

93. Wegener's granulomatosis presenting as neutrophilic dermatosis: a case report.

Gurses L., Yucelten D., Comert A., Ergun T., Gurbuz O.

The British journal of dermatology , cilt.143, sa.1, ss.207-9, 2000 (SCI-Expanded)

94. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease.

Direskeneli H., Eksioglu-Demiralp E., Yavuz S., Ergun T., Shinnick T., Lehner T., et al.

The Journal of rheumatology , cilt.27, sa.3, ss.708-13, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

95. Oligoclonal T cell expansions in patients with Behçet's disease.

Direskeneli H., Eksioglu-Demiralp E., Kibaroglu A., Yavuz S., Ergun T., Akoglu T.

Clinical and experimental immunology , cilt.117, sa.1, ss.166-70, 1999 (SCI-Expanded)

96. Ecthyma gangrenosum.

Gucluer H., Ergun T., Demircay Z.

International journal of dermatology , cilt.38, sa.4, ss.299-302, 1999 (SCI-Expanded)

97. Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease.

Eksioglu-Demiralp E., DİRESKENELİ R. H., Ergun T., Fresko I., Akoglu T.

Rheumatology international , cilt.19, sa.1-2, ss.23-6, 1999 (SCI-Expanded, Scopus)

98. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet's disease

Ergun T., Gurbuz O., Harvell J., Jorizzo J., White W.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.37, sa.12, ss.929-933, 1998 (SCI-Expanded)

99. Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders.

Budak-Alpdoǧan T., Demirçay Z., Alpdoǧan Ö., DİRESKENELİ R. H., Ergun T., Öztürk A., et al.

British journal of rheumatology , cilt.37, sa.11, ss.1148-51, 1998 (SCI-Expanded, Scopus)

100. Phagocytosis and oxidative burst by neutrophils in patients with recurrent furunculosis.

Demirçay Z., Ekşioğlu-Demiralp E., Ergun T., Akoğlu T.

The British journal of dermatology , cilt.138, sa.6, ss.1036-8, 1998 (SCI-Expanded)

101. Histopathologic features of the spontaneous pustular lesions of Behcet's syndrome

Ergun T., Gurbuz O., Dogusoy G., Mat C., Yazici H.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.37, sa.3, ss.194-196, 1998 (SCI-Expanded)

102. Topical cyclosporine-A for treatment of oral ulcers of Behçet's syndrome.

Ergun T., Gürbüz O., Yurdakul S., Hamuryudan V., Bekiroğlu N., Yazici H.

International journal of dermatology , cilt.36, sa.9, ss.720, 1997 (SCI-Expanded)

103. Behcet's disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms

BudakAlpdogan T., Demircay Z., Alpdogan O., DİRESKENELİ R. H., Ergun T., Bayik M., et al.

ANNALS OF HEMATOLOGY , cilt.74, sa.1, ss.45-48, 1997 (SCI-Expanded)

104. Re-evaluation of skin-explant model in graft-versus-host disease prediction.

Sahin S., Akoğlu T. F., Gürbüz O., Ergun T., Küllü S., Sav A., et al.

Clinical transplantation , cilt.9, sa.5, ss.370-4, 1995 (SCI-Expanded)

105. PARTIAL LIPODYSTROPHY

GURBUZ O., YUCELTEN D., ERGUN T., KHALILAZER R.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.34, sa.1, ss.36-37, 1995 (SCI-Expanded)

106. PROTEUS-SYNDROME - CLINICAL-FEATURES AND DIFFERENTIAL-DIAGNOSIS

BAYKAL C., GOGUS A., GURSOY E., ERGUN T., DOMANIC U.

HAUTARZT , cilt.45, sa.4, ss.237-242, 1994 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 53

1. Patients with Oral Ulcers Display High Levels of Salivary Acidic Glycoproteins in Behçet’s Syndrome

ÇEVİK ARAS H., POLAT AKMANSOY B., SARI F. B., AKMANSOY Ş. C., TATLI İ., ALİBAZ ÖNER F., et al.

The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 Ekim 2024, ss.40, (Özet Bildiri)

2. Identifying Low Disease Activity and Its Related Factors in Behçet's Syndrome through K-Means Cluster Analysis and Correspondence Analysis

POLAT AKMANSOY B., AKSOY B., ÇANDERELİ Z. Ö., SACOOR S., GOKANİ B., ALİBAZ ÖNER F., et al.

The Joint Meeting of The European Association of Oral Medicine Region V, İstanbul, Türkiye, 25 - 27 Ekim 2024, (Özet Bildiri)

3. Netherton Sendromlu Bir Olguda Dupilumab Tedavisi

AKTAŞ M., SALMAN A., APTİ ŞENGÜN Ö., CÖMERT E., HOŞGÖREN F. S., AKIN ÇAKICI Ö., et al.

. XXIV. Prof. Dr. A. Lütfü Tat Sempozyumu, Türkiye, 20 - 24 Kasım 2019

4. BEHÇET HASTALARINDA MUKOKUTANÖZ AKTİVİTE İNDEKSİ İÇİN YAŞ MODERATÖR ETKİYE SAHİP Mİ? ÇOK MERKEZLİ ULUSAL ÇALIŞMA

MUMCU G., YAY M., KARAÇAYIRLI Ü., TAŞ M. N., SARI A., BOZCA B. C., et al.

20. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 16 - 20 Ekim 2019, (Tam Metin Bildiri)

5. Dermatolojideki taklitçi: Bir hatırlatma

SARAÇ G., AKIN ÇAKICI Ö., DEMİR G., CÖMERT E., HOŞGÖREN F. S., ERGUN S. A. T., et al.

10. Dermatoloji Bahar Sempozyumu, Türkiye, 10 - 13 Nisan 2019

6. Sistemik Antipsoriatik Tedavinin Depresyonun Subjektif ve Biyokimyasal Göstergelerine Etkisi.

AKSOY H., ERGUN S. A. T., AKKİPRİK M., PEKER EYÜBOĞLU İ., SEÇKİN GENÇOSMANOĞLU D., CÖBEK ÜNALAN G. P., et al.

dermatoloji bahar sempozyumu, 10 - 13 Nisan 2019, (Özet Bildiri)

7. İleri glikasyon son ürünleri: Psoriasis ve kardiyovasküler hastalık arasında olası bir bağlantı

ERGUN S. A. T., YAZICI V., YAVUZ D., SEÇKİN GENÇOSMANOĞLU D., ÖZEN G., SALMAN A., et al.

27. Ulusal Dermatoloji Kongresi, Türkiye, 16 - 20 Ekim 2018 Sürdürülebilir Kalkınma

8. Another cause of the raccoon eyes: sweet syndrome

SALMAN A., DEMİR G., CİNEL Z. L., OĞUZSOY T., TEMİZ S. G., ERGUN S. A. T.

27th EADV Congress, Fransa, 12 - 16 Eylül 2018

9. Atopik Dermatit’li Hastalarda Dental Folikül Kök Hücrelerin Naive T Lenfositlerin Th1 ve Th2 Yönünde Farklılaşması Üzerine Etkisi

Zibandeh N., GENÇ D., ERGUN S. A. T., ÖZGEN Z., BARIŞ S., Duran Y., et al.

24. Ulusal Allerji ve Klinik İmmünoloji Kongresi, Türkiye, 18 - 22 Kasım 2017, (Özet Bildiri)

10. Dermoskopik olarak seboreik keratozu andıran bir dermatofibrom olgusu

SARAÇ G., SEÇKİN GENÇOSMANOĞLU D., ERÇETİN S. Y., CİNEL Z. L., ERGUN S. A. T.

223. Lütfü Tat Sempozyumu, Türkiye, 22 - 26 Kasım 2017, (Özet Bildiri)

11. Erişkin Ailesel Akdeniz Ateşi hastalarında psöriasis sıklığı artmış mıdır?

AKSOY A., ÖZGEN Z., GAZEL Ü., İNANÇ G. N., ATAGÜNDÜZ M. P., ERGUN S. A. T., et al.

18. Ulusal Romatoloji Kongresi, Türkiye, 18 - 22 Ekim 2017, (Özet Bildiri)

12. ILLNESS PERCEPTION IN PATIENTS WITH BEHCET DISEASE EMOTIONAL REACTIONS TO DISEASE SYMPTOMS

ERGUN S. A. T., İNANÇ G. N., DİRESKENELİ R. H., MUMCU G.

17th International Conference on Behçet's Disease, 15 - 17 Eylül 2017, cilt.34, (Özet Bildiri)

13. Lupus erythematosus panniculitis treated with stromal vascular fraction

ERGUN S. A. T., ÇAVUŞ ÖZKAN M., SALMAN A.

THE AMERİCAN ACADEMY OF DERMATOLOGY 2017 ANNUAL MEETİNG, 3 - 06 Mart 2017, cilt.76, ss.163, (Özet Bildiri)

14. VENOUS VESSEL WALL THICKNESS IN LOWER EXTREMITY IS INCREASED IN MALE BEHCET DISEASE PATIENTS WITHOUT VASCULAR INVOLVEMENT

ALİBAZ ÖNER F., MUTİS A., ERGELEN R., ERGUN S. A. T., DİRESKENELİ R. H.

18th International Vasculitis and ANCA Workshop, 25 - 28 Mart 2017, (Özet Bildiri)

15. Alışılmadık bir oküler rozasea olgusu.

ÇELİKER H., TOKER A. E., ERGUN S. A. T.

TOD 50. ULUSAL KONGRESİ, Türkiye, 9 - 13 Kasım 2016, (Özet Bildiri)